ArticleJournal of advanced research2026
HDAC3 represses Nrf2-GDF11 signaling to drive chondrocyte adipogenesis in temporomandibular joint osteoarthritis.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAberrant biomechanical force-induced chondrocyte adipogenesis is involved in the development of temporomandibular joint osteoarthritis (TMJ OA). Growth differentiation factor 11 (GDF11) has been implicated in this process. However, whether mechanosensitive histone deacetylase 3 (HDAC3) regulates GDF11 signaling in the context of TMJ OA remains to be elucidated.
objectiveTo elucidate the HDAC3-mediated regulation of GDF11 during chondrocyte adipogenesis in TMJ OA.
methodsA unilateral anterior crossbite (UAC) rat model and cyclic tensile strain (CTS)-stimulated ATDC5 cells were established to mimic aberrant biomechanical force. Cartilage degeneration was assessed via Safranin O staining and qRT-PCR. Chondrocyte adipogenesis was evaluated using Oil Red O staining, transmission electron microscopy (TEM), and Adiponectin immunohistochemistry (IHC). The expression of HDAC3, nuclear factor erythroid 2-related factor 2 (Nrf2), and GDF11 was quantified by IHC, qRT-PCR, and western blotting. The binding of Nrf2 to GDF11 was evaluated by dual-luciferase reporter assays. The therapeutic interventions included intra-articular injections of the HDAC3 inhibitor RGFP966 (10 mg/kg) and the Nrf2 agonist Bardoxolone (10 mg/kg).
resultsThe articular cartilage was significantly thinner, the modified Osteoarthritis Research Society International (OARSI) scores were increased, the expression of cartilage matrix markers (collagen II and aggrecan) was reduced, and the expression of chondrocyte hypertrophic markers (collagen X, matrix metalloprotease-13, and alkaline phosphatase) was increased in the UAC-induced OA model group compared with the sham control group. Excessive biomechanical force accelerated chondrocyte adipogenesis, as indicated by increased lipid droplet accumulation and Adiponectin upregulation. Concurrently, HDAC3 was upregulated, which suppressed Nrf2 and downregulated GDF11. Dual-luciferase reporter assays confirmed the direct binding of Nrf2 to the GDF11 promoter in chondrocytes. Treatment with the HDAC3 inhibitor RGFP966 or the Nrf2 agonist Bardoxolone restored GDF11 expression, significantly attenuating adipogenesis and alleviating cartilage degeneration.
conclusionsOur findings indicate that aberrant biomechanical force induces HDAC3 upregulation, which suppresses Nrf2-mediated transactivation of GDF11, thereby promoting chondrocyte adipogenesis and exacerbating TMJ OA progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.